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Peptides recently isolated and sequenced from a bacterial (Leuconostoc mesenteroides) glucose-6-phosphate 
dehydrogenase are remarkably homologous to an active site region of the human erythrocyte enzyme, al- 
though the enzymes differ in their overall amino acid composition and kinetic properties. The computer 
program ALIGN, used to determine the best alignment between the two enzyme sequences, gives match- 
scores which are statistically highly significant. 
Glucose-6-phosphate dehydrogenase: Sequence homology; (Human erythrocyte, Leuconostoc mesenteroides) 
1. INTRODUCTION 
Glucosed-phosphate dehydrogenase (D-glu- 
cose-6-phosphate : NADP+ I -oxidoreductase, EC 
1.1.1.49) from Leuconostoc mesenteroides 
catalyzes the oxidation of glucose 6-phosphate by 
either NADP+ or NAD+, both in vitro [l] and in 
vivo [2]. This enzyme serves two distinct metabolic 
functions, depending on whether it utilizes 
NADP+ or NAD+ [2]. Mechanisms whereby the 
choice of coenzyme utilization are regulated have 
been proposed [3,4] and depend on differences be- 
tween the steady-state kinetic mechanisms of the 
NADP- and NAD-linked reactions [5]. Ex- 
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periments have been reported that document dif- 
ferences between the conformations of the L. 
mesenteroides G6PD-NADP+ and NAD+ com- 
plexes [6,7]. 
The dual nucleotide coenzyme specificity of L. 
mesenteroides G6PD contrasts sharply with the 
NADP+ specificity of most other G6PDs under 
physiological conditions [8]. These NADP- 
preferring G6PDs catalyze the first reaction of the 
hexose monophosphate shunt pathway which 
generates pentoses required for the biosynthesis of 
nucleic acids and several coenzymes, and produces 
NADPH required for a variety of biosynthetic and 
detoxication reactions. Human erythrocyte G6PD 
is of special interest because of the very large 
number of variants found in the human population 
and their correlation with clinical problems such as 
various hemolytic abnormalities [9]. Despite the 
importance of the human G6PD, few structural 
studies have been reported on this enzyme 
[8,10,11]. 
As an extension of our previous investigations of 
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the L. mesenteroides G6PD and as part of our in- 
terest in understanding the structural basis of its 
dual nucleotide specificity, we are determining the 
enzyme’s complete amino acid sequence and its 
three-dimensional structure using X-ray crystal- 
lographic techniques [ 121; preliminary X-ray 
studies on the rat liver enzyme have also been 
reported [ 131. 
Two recent reports of the complete amino acid 
sequence of human G6PD [ 14,151 are in agreement 
for 479 residues from the C-terminus with only 3 
exceptions, but the sequence of Takizawa et al. 
[ 151 contains 52 additional residues N-terminal to 
the first residue of the sequence of Persico et al. 
[14]. A reactive lysine residue has been labelled on 
G6PD from L. mesenteroides [16], baker’s yeast 
[17] and human erythrocytes [18,19], and 
fragments containing this lysine have been se- 
quenced for all but the human enzyme. The ten- 
tative amino acid sequence of the human enzyme 
proposed by Beutler [ll] contains a fragment ex- 
tensively homologous to the yeast reactive lysine 
peptide [ 171 and the homology is now confirmed in 
the complete sequence of the human enzyme. The 
amino acid sequence of the L. mesenteroides 
G6PD peptide containing the reactive lysine show- 
ed more differences from, than similarities to, 
either of the other peptides and it was therefore 
concluded that the L. mesenteroides nzyme is very 
different from the human enzyme. On the basis of 
the recent amino acid sequencing results, we wish 
to point out that this is not so and that remarkable 
similarity exists between the L. mesenteroides and 
the human G6PDs in the active site region of the 
human enzyme. 
2. MATERIALS AND METHODS 
L. mesenteroides G6PD was obtained from 
Cooper Biomedical, Inc. Cyanogen bromide 
cleavage [20] yielded 4-5 broad peaks when the 
peptides were subjected to HPLC using TSK250 
and TSK125 gel filtration columns in tandem. 
These were resolved into individual peptides using 
a Waters PBondapak Cis column. During the 
overall sequencing strategy, which will be de- 
scribed elsewhere, several peptides were obtained 
from native L. mesenteroides G6PD by cleavage 
with various proteases, one of which was ther- 
molysin. The sequence of one of the thermolytic 
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peptides, T-10, overlapped with that of CNBr pep- 
tide C-3b. Isolated peptides were sequenced by Ed- 
man degradation using an Applied Bio-Systems 
gas-phase model 470A protein/peptide sequencer 
[21]. PTH-amino acids were identified by a minor 
modification of the method of Johnson et al. [22]. 
We have used a computer program ALIGN [23] 
based on the algorithm of Needleman and Wunsch 
[24] to find the best alignment between two amino 
acid sequences and its statistical significance. An 
alignment score is calculated by taking the dif- 
ference between the maximum match score and the 
maximum match score for average random per- 
mutations of the two sequences and dividing by the 
standard deviation of the random scores [24]. In- 
sertions and deletions may be accommodated by 
allowing a break in either sequence. However, with 
each break in the sequence, the match score is 
reduced by an amount (break penalty parameter) 
specified by the user. If the alignment score is more 
than 3 standard deviations, with or without allow- 
ing breaks, the sequence homology can be con- 
sidered statistically significant. 
3. RESULTS AND DISCUSSION 
The sequence of L. mesenteroides G6PD pep- 
tides C-3b and T-10 revealed that there was signifi- 
cant overlap between the C-terminal end of the 
former and the N-terminus of the latter, thus ex- 
tending the sequence of C-3b to give a 42-residue 
peptide. The alignment of this sequence to that of 
the human erythrocyte enzyme [14], as shown in 
fig. 1, gave the alignment score shown in table 1. A 
maximum alignment score of 15.2 standard devia- 
tions was found for this peptide without 
necessitating any breaks in the sequence. This 
clearly shows a high degree of homology between 
the L. mesenteroides and human G6PDs. As is 
seen from fig. 1, the 42 residues of the L. 
mesenteroides enzyme align best with residues 
133-174 of the human enzyme. Five consecutive 
residues starting from 134 are identical, only 4 
non-consecutive residues match between 139 and 
161, a region in which there are several 
replacements but no insertions or deletions. Finally 
and most interestingly, the last 13 residues of this 
peptide match entirely with residues 162-174 of 
the human enzyme, the region containing the reac- 
tive lysine (residue 169) in this enzyme. The 
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Fig.1. L. mesenteroides G6PD peptides. C-3b and T-10 aligned with human erythrocyte G6PD sequence. Reactive 
Lys-169 is underlined. * Sequence contains either L or F at this position. Both give very similar alignment scores. 
&residue peptide thought to contain the essential 
lysine in L. mesenteroides G6PD [16] gives align- 
ment scores close to zero with both the human se- 
quences [14,15] suggesting that this region which 
might be important in the activity of the L. 
mesenteroides enzyme is not conserved in the 
human enzyme. The 11 residues around the reac- 
tive lysine of the human and yeast enzymes, 
together with the homologous peptide fragment of 
Table 1 
Alignment scores for the L. mesenteroides G6PD 
peptides 
Peptide 
C-3b 
T-10 
C-3b and T-10 
No. of 
residues 
37 
8 
42 
Alignment score 
(in SD units) 
11.6 
8.5 
15.2 
Human erythrocyte IDHYLGXEMVQ 
L. mesenteroides IDHYLGKEMVQ 
S. cerevisiae IDHYLGKELVK 
L. mesenteroides G6PD are shown in fig.2. These 
11 residues are entirely identical in the L. 
mesenteroides and human enzymes and almost 
identical in the yeast enzyme. A sequence identical 
for these 11 residues with that of the human and L. 
mesenteroides enzymes has also been reported for 
Drosophila melanogaster (Manning quoted in 
U41). 
The L. mesenteroides G6PD differs from the 
human enzyme in its amino acid composition and 
kinetic properties. The L. mesenteroides enzyme 
can utilize both NADP+ and NAD+ for its 
catalytic reaction, whereas the human enzyme is 
highly specific for NADP+; the L. mesenteroides 
enzyme contains no cysteines whereas the human 
enzyme contains 18 of these residues and there are 
large differences in the contents of several other 
amino acids; unlike the human enzyme, L. 
mesenteroides G6PD is not inhibited by steroids 
[8]. Although these two enzymes are distant in 
Fig.2. Peptides containing the reactive lysine (underlined) of various G6PDs. 
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evolutionary terms, the sequence comparisons 
reported here strongly suggest that the two en- 
zymes are structurally related. 
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